Augmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab. [electronic resource]
Producer: 20200330Description: 1151-1153 p. digitalISSN:- 1527-7755
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.